NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/10/2024
Back to search
Official data from USPTO
MTF BIOLOGICS SCIENCE DRIVEN. PATIENT FOCUSED.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
09/10/2024
Trademark type
Combined
Nice classes
5, 40, 44
Filing date
06/13/2017
Registration date
02/12/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2024
Last transaction
09/10/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2018-09-00
First use in commerce
2018-09-00
Drawing code
3
Owner type
16
Owner location
Edison, NJ, US
Examiner
DINALLO, KEVIN M
Current location
FILE DESTROYED
Mark description
The mark consists of the word "MTF" in orange, and the word "BIOLOGICS" in blue, with a dotted arc in blue over the word "BIOLOGICS", a black line extending below the words "MTF" and "BIOLOGICS", and the phrase "SCIENCE DRIVEN. PATIENT FOCUSED." written in black below the black line.
Holders and representatives
Holders
M. F. (pessoa física)
Representatives
William W. Stroever Cole Schotz P.C.
Technical classification
Nice Classes
Class 5Class 40Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Allograft materialprocessed human bone and tissue for use in surgical or medical procedures; Allograft materialhuman bone and tissue processed into implantsscaffoldspowdersgelspastesputtymatsfilmsstripssheetsmolded piecessurgical patchesplugswound dressingswound coverings; Growth factorsproteins for promoting tissue growth and repairprocessed into surgical implantsscaffolds and plugs for the repair and replacement of human bone and tissue defects; Processed acellular human dermis and fascia tissue intended for subsequent implantation or for use in cosmetic surgery; Human allograft tissue derived from dermis; Human allograft tissue for topical use comprised of tissue from placental membranes; Human allograft tissue derived from placental tissue; Human allograft tissue derived from adipose matrix; Adipose cavity filler; Soft tissue implant for use in surgery; Bone void fillers consisting of biological materials; Bone void fillers consisting of natural materials; Cartilage implants derived from living tissue; Hydrated packaging containers specially designed for transporting and holding allograft implants made from living tissue and bone
Class 40
Human allograft tissue processing servicespreparing biological tissue for subsequent implantation in the human body
Class 44
Human allograft tissue bank donor services; Maintaining files and records concerning the donation of human tissue between and among the hospitaldonor and recipient; Medical services in the field of human tissuecellsbone and organ donationsobtaining donor consent and human donor referralsconducting donor screening surveyscollecting donor medical datacoordinating donor recoveries with outside entitiesproviding statistical donor data to others
Publications
History of USPTO decisions and trademark events.
45 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/10/2024
E815
TEAS SECTION 8 & 15 RECEIVED
02/26/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/12/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/10/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/04/2019
GNRT
NON-FINAL ACTION E-MAILED
01/04/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/04/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/28/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/27/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
12/27/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/20/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/17/2018
IUAF
USE AMENDMENT FILED
11/28/2018
DRRR
DIVISIONAL REQUEST RECEIVED
11/28/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
11/28/2018
EISU
TEAS STATEMENT OF USE RECEIVED
11/28/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/19/2018
EX1G
SOU EXTENSION 1 GRANTED
06/15/2018
EXT1
SOU EXTENSION 1 FILED
06/15/2018
EEXT
SOU TEAS EXTENSION RECEIVED
06/15/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/03/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/03/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/26/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/31/2017
PUBO
PUBLISHED FOR OPPOSITION
10/31/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/11/2017
ALIE
ASSIGNED TO LIE
09/22/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/07/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/07/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
09/07/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/07/2017
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/01/2017
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
09/01/2017
DOCK
ASSIGNED TO EXAMINER
08/29/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/20/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/19/2017
NWAP
NEW APPLICATION ENTERED
06/16/2017
Continuous trademark protection
Get notified about every new filing that threatens MTF BIOLOGICS SCIENCE DRIVEN. PATIENT FOCUSED. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.